Evidence map›Paper›PMID 39623803›Full record

ArticleAdvanced healthcare materials2025

Acute Three-Dimensional Hypoxia Regulates Angiogenesis.

Dimitris Ntekoumes, Jiyeon Song, Haohao Liu, Connor Amelung, Ya Guan, Sharon Gerecht

Abstract read
In one paragraph

Article in Advanced healthcare materials, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Acute Three-Dimensional Hypoxia Regulates Angiogenesis.Advanced healthcare materials · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Dimitris NtekoumesDepartment of Biomedical Engineering, Duke University, Durham, NC, 27708, USA.
Jiyeon SongDepartment of Biomedical Engineering, Duke University, Durham, NC, 27708, USA.
Haohao LiuDepartment of Biomedical Engineering, Duke University, Durham, NC, 27708, USA.
Connor AmelungDepartment of Biomedical Engineering, Duke University, Durham, NC, 27708, USA.
Ya GuanDepartment of Biomedical Engineering, Duke University, Durham, NC, 27708, USA.
Sharon GerechtDepartment of Biomedical Engineering, Duke University, Durham, NC, 27708, USA.ORCID 0000-0002-8542-4835

Funding

Onassis Foundation F ZQ 046-1/2020-2021U.S. Air Force FA9550-20-1-0356
6 · The paper itself

Abstract

Hypoxia elicits a multitude of tissue responses depending on the severity and duration of the exposure. While chronic hypoxia is shown to impact development, regeneration, and cancer, the understanding of the threats of acute (i.e., short-term) hypoxia is limited mainly due to its transient nature. Here, a novel gelatin-dextran (Gel-Dex) hydrogel is established that decouples hydrogel formation and oxygen consumption and thus facilitates 3D sprouting from endothelial spheroids and, subsequently, induces hypoxia "on-demand." The Gel-Dex platform rapidly achieves acute moderate hypoxic conditions without compromising its mechanical properties. Acute exposure to hypoxia leads to increased endothelial cell migration and proliferation, promoting the total length and number of vascular sprouts. This work finds that the enhanced angiogenic response is mediated by reactive oxygen species, independently of hypoxia-inducible factors. Reactive oxygen species-dependent matrix metalloproteinases activity mediated angiogenic sprouting is observed following acute hypoxia. Overall, the Gel-Dex hydrogel offers a novel platform to study how "on-demand" acute moderate hypoxia impacts angiogenesis, with broad applicability to the development of novel sensing technologies.

Indexed as

HypoxiaNeovascularization, PhysiologicAngiogenesisCell HypoxiaCell MovementCell ProliferationDextransGelatinHumansHuman Umbilical Vein Endothelial CellsHydrogelsReactive Oxygen SpeciesSpheroids, CellularDextransGelatinHydrogelsReactive Oxygen Speciesangiogenesisendothelial cellshydrogelhypoxiareactive oxygen species

Identifiers

PMID39623803
PMCPMC11729260

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.